Valuation: Amgen Inc.

Market Cap 195B 170B 157B 147B 276B 18,399B 281B 1,886B 732B 9,079B 731B 715B 31,630B P/E 2026 *
23.5x
P/E 2027 * 21.6x
Enterprise Value 236B 207B 191B 178B 336B 22,342B 342B 2,290B 889B 11,025B 888B 868B 38,409B EV / Sales 2026 *
6.26x
EV / Sales 2027 * 5.96x
Free-Float
99.78%
Yield 2026 *
2.8%
Yield 2027 * 2.96%
1 day+0.01%
1 week+4.19%
Current month+7.35%
1 month+9.85%
3 months+3.60%
6 months+10.00%
Current year+10.46%
1 week 346
Extreme 346
363.11
1 month 322.3
Extreme 322.3
363.11
Current year 318.21
Extreme 318.21
391.29
1 year 269.77
Extreme 269.77
391.29
3 years 218.44
Extreme 218.44
391.29
5 years 198.64
Extreme 198.64
391.29
10 years 133.64
Extreme 133.64
391.29
Manager TitleAgeSince
Chief Executive Officer 63 2012-04-30
Director of Finance/CFO 67 2019-12-31
Chief Operating Officer 59 2016-07-24
Director TitleAgeSince
Chairman 63 2012-12-31
Director/Board Member 65 2011-12-31
Director/Board Member 71 2011-12-31
Date Insider Type Main position Quantity % Market Cap.
May. 18Free

Director

665 0.0001%
May. 18Free

Director

665 0.0001%
May. 18Free

Director

665 0.0001%
Change 5-day change 1-year change 3-year change Capi.($)
+0.01%+4.19%+29.49%+62.85% 195B
-1.58%+9.50%+55.51%+158.49% 1,097B
-1.00%+7.32%+67.97%+55.01% 622B
-1.32%+7.39%+35.82%+87.11% 449B
-1.62%+6.34%+29.51%+24.01% 334B
-1.38%+3.75%+39.33%+25.04% 294B
+0.30%+2.56%+31.62%+40.64% 286B
-0.10%+2.23%-28.43%-42.77% 213B
-0.11%+1.03%+13.95%+63.93% 157B
-1.01%-2.35%-0.41%-34.19% 139B
Average -0.71%+5.74%+27.43%+44.01% 378.56B
Weighted average by Cap. -1.02%+8.26%+40.03%+74.65%

Financials

2026 *2027 *
Net sales 37.76B 33.05B 30.51B 28.46B 53.63B 3,570B 54.59B 366B 142B 1,762B 142B 139B 6,138B 38.71B 33.89B 31.28B 29.18B 54.98B 3,660B 55.96B 375B 146B 1,806B 145B 142B 6,293B
Net income 8.23B 7.21B 6.65B 6.2B 11.69B 778B 11.9B 79.78B 30.97B 384B 30.93B 30.24B 1,338B 8.86B 7.76B 7.16B 6.68B 12.59B 838B 12.81B 85.92B 33.36B 414B 33.31B 32.56B 1,441B
Net Debt 41.7B 36.5B 33.7B 31.43B 59.22B 3,943B 60.28B 404B 157B 1,946B 157B 153B 6,779B 36.06B 31.56B 29.13B 27.18B 51.21B 3,409B 52.12B 349B 136B 1,682B 135B 132B 5,861B
Logo Amgen Inc.
Amgen Inc. is one of the world's leading biotechnology groups. Net sales break down by source of revenue as follows: - drug sales (95.8%): drugs for treating cancer, metabolic disorders, bone diseases, renal failure, hemophilia, etc.; - other 4.2%): primarily royalties. The United States account for 71.9% of net sales.
Employees
31,500
Date Price Change Volume
26-06-30 $362.33 +0.49% 1,075,944
26-06-29 $360.55 +0.62% 2,461,887
26-06-26 $358.33 +1.56% 3,610,561
26-06-25 $352.82 +0.40% 2,341,847
26-06-24 $351.43 +1.27% 2,391,890
Trader
Investor
Global
Quality
ESG MSCI
A
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
34
Last Close Price
360.55USD
Average target price
354.76USD
Spread / Average Target
-1.61%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. AMGN Stock